About
Jaguar Animal Health Inc (NASDAQ:JAGX) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 24 2026
Jaguar Health Announces Acceptance of two Late-Breaking Abstracts for Liquid Oral Crofelemer Treatment of Intestinal Failure in Pediatric Patients at the European Society for Pediatric Gastroenterology, Hepatology & Nutrition (ESPGHAN)
Apr 20 2026
Jaguar Health Reports Approval of All Proposals at April 2026 Special Meeting of Stockholders
Apr 8 2026
Jaguar Health Completes Effectiveness Trial to Support FDA Approved Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
Apr 7 2026
Jaguar Health Reports 2025 Financials
Apr 2 2026
Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress
Financials
Revenue
$11.79 M
Market Cap
$4.97 M
EPS
-2.58
Google Übersetzer